| Stock (Symbol) | Stock Price | |
Intuitive Surgical (ISRG) |
$511 |
|
| Data is as of | Expected to Report | Sector |
August 13, 2012 |
Oct 18 |
Healthcare |
| Sharek’s Take | ||
 When I did my research report on ISRG last quarter the stock was on a 14-week winnings streak. That streak extended one more week before the stock went into a little three-week correction. Now ISRG is building a base, but the stock is sitting at its Fair Value so don’t expect big gains until the New Year approaches.Last quarter was good. Revenue was up 26%, just a little less than the 28% growth seen the prior two quarters. da Vinci revenue grew 23% and replacement parts revenue grew 28%. Now parts revenue (the safe recurring revenue) is 57% of total sales, it used to be 50%. |
||
| One-Year Chart | ||
|
|
||
| Earnings Table | ||
 Profits grew only 21% last quarter, on a 26% increase in sales. I don’t like to see the slowing growth, but I think 30% growth will come next quarter.Intuitive Surgical continues to crush estimates — and has done so every quarter since 2009 Q2. Annual Profit Estimates continue to climb, but at a slower rate than in 2011. Quarterly estimates fell some and there’s two quarters of so-so growth expected. Again, ISRG should beat the street so I’m not concerned. |
||
| Fair Value | ||
 ISRG is selling right where it should be. I hold it because I’ve had it a while and its a long-term investment. |
||
| Ten-Year Chart | ||
 ISRG has been one of the top stocks in the last decade. I originally purchased shares at $29 on 10/27/04. Should have held all of them. Now ISRG has to digest the last big run-up, this stock might not move again until 2013. |
||
| Power Ranking | Bottom Line | |
Growth Portfolio
14 of 16 |
Intuitive Surgical probably won’t do anything for another three-to-six months. The stock is selling at its Fair Value and doesnt’ have momentum to push it much higher. |
|
Aggressive Growth Portfolio
N/A |
||
This stock’s been hanging-in-there considering it went from $330 to $590 within one year. Now with a P/E of 34 this stock is where it should be. ISRG was a little overvalued last quarter. It looks like 